Search results for: 'pace technology industry'

In the rapidly evolving landscape of 2025, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

The healthcare industry is undergoing a massive transformation, with a high focus on personalization and patient-centric care. It is embracing digital transformation and becoming more consumer-/patient friendly. The changing socioeconomic landscape, the high prevalence of chronic diseases, the massive COVID-19 pandemic, and the challenge of resourc...

Rising healthcare and surgery costs are increasing the burden on healthcare systems, making it difficult for hospitals to offer high-quality care at affordable prices. Time-consuming manual processes that significantly impact surgeon time and workload, hospital cost increases due to delayed surgery, and low patient satisfaction levels due to human ...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

In almost all parts of the world, women live longer than men. The exact cause behind the differential between male and female life expectancy is uncertain, but it appears to be partly explained by biological advantages and partly by environmental and behavioral factors. However, as women outlive men, they are more prone to suffering from ill healt...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

The neuroimaging industry is dynamic, constantly looking for novel approaches to identify and cure complex neurological disorders. Emerging MRI and CT technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety. This study examines emerging technologies, ...